Evidence map›Paper›PMID 32763162›Full record

ArticleStem cell reports2020

A Semi-automated and Scalable 3D Spheroid Assay to Study Neuroblast Migration.

Martin Ducker, Valerie Millar, Daniel Ebner, Francis G Szele

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Hydrogel Design to Understand and Guide 3D Cell Migration.Regenerative engineering and translational medicine · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Martin DuckerDepartment of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK.
Valerie MillarTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Daniel EbnerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Francis G SzeleDepartment of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK. Electronic address: francis.szele@dpag.ox.ac.uk.
University of Oxford · GB

Funding

Illuminating Function of the Understudied Druggable KinomeU24DK116204 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSON, GARY L. · 2017 to 2022
$13.6M
Creation of in vivo active chemical probes for CAMKK2 to treat cancerR01CA218442 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DREWRY, DAVID HAROLD · 2017 to 2019
$2.0M
Tools for Accelerating R&D for Historically Understudied Protein KinasesR44TR001916 · NCATS · LUCEOME BIOTECHNOLOGIES, LLC · PI ZUTSHI, REENA · 2017 to 2018
$1.4M
NCATS NIH HHS R44 TR001916NCI NIH HHS R01 CA218442NIDDK NIH HHS U24 DK116204Wellcome Trust
6 · The paper itself

Abstract

The subventricular zone of the mammalian brain is the major source of adult born neurons. These neuroblasts normally migrate long distances to the olfactory bulbs but can be re-routed to locations of injury and promote neuroregeneration. Mechanistic understanding and pharmacological targets regulating neuroblast migration is sparse. Furthermore, lack of migration assays limits development of pharmaceutical interventions targeting neuroblast recruitment. We therefore developed a physiologically relevant 3D neuroblast spheroid migration assay that permits the investigation of large numbers of interventions. To verify the assay, 1,012 kinase inhibitors were screened for their effects on migration. Several induced significant increases or decreases in migration. MuSK and PIK3CB were selected as putative targets and their knockdown validated increased neuroblast migration. Thus, compounds identified through this assay system could be explored for their potential in augmenting neuroblast recruitment to sites of injury for neuroregeneration, or for decreasing malignant invasion.

Indexed as

Cell MovementAnimalsAutomationBiological AssayClass I Phosphatidylinositol 3-KinasesFluorescent DyesGene Knockdown TechniquesImage Processing, Computer-AssistedLateral VentriclesMiceNeuronsProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesReceptors, CholinergicReproducibility of ResultsSpheroids, CellularClass I Phosphatidylinositol 3-KinasesFluorescent DyesMUSK protein, humanPIK3CB protein, humanProtein Kinase InhibitorsReceptor Protein-Tyrosine KinasesReceptors, Cholinergic3Dassaycancerdrug discoveryimagingmigrationneuroblastsregenerative medicinescreensubventricular zone

Identifiers

PMID32763162
PMCPMC7486343
OpenAlexW3047531668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.